Astra Buying Bristol Makes No Sense, Fazeli Says

Big deal in the pharma space. AstraZeneca down 7%, Bristol-Myers up 2.7%. After the companies reportedly held early stage talks for a potential merger.That combination would create the world's biggest drug maker with about $107 billion in annual revenue. Let's bring in Bloomberg Intelligence senior pharmaceutical analyst Sam Ali for more on this. Sam, what would be the reasoning. What would be the logic behind forming such a behemoth of a drug company.Um, none. Zero. There's really no, uh, I mean, every cli ...